Microbiology CRO Services Market Growth and Analysis by 2031

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Microbiology CRO Services Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography

  • Report Date : Oct 2024
  • Report Code : TIPRE00039340
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 227

The Microbiology CRO Services market size is projected to reach US$ 11.51 billion by 2031 from US$ 5.52 billion in 2023. The market is expected to register a CAGR of 9.6% during 2023–2031. The integration of artificial intelligence and machine learning is likely to act as a future trend in the market.

Microbiology CRO Services Market Analysis

Microbial testing CROs offer specialized services, including bacterial identification, antimicrobial susceptibility testing, sterility testing, bioburden testing, and molecular testing, to support these research and development efforts. The increasing demand for personalized medicine, targeted therapies, and implantable devices is also increasing the need for microbial testing CROs to provide customized testing services. Thus, increasing research and development investments fuel the microbiology CRO market growth. Moreover, the increasing number of clinical trials and the practice of outsourcing trials to CROs is contributing to the market growth.

Microbiology CRO Services Market Overview

Germany is expected to register the highest CAGR in the microbiology CRO services market in Europe during the forecast period. Germany is expected to be among the significant contributors to the growth of the microbiology CRO services market owing to the increasing number of clinical trials. According to Clinical Trials Arena, Germany held ~3.9% of the total clinical trials carried out worldwide in 2021. Germany has a massive patient pool and a high demand for quality healthcare. Coordinating centers for clinical trials were set up as part of a new funding program under the Federal Ministry of Education and Research to further encourage academic clinical research. The Federal Institute for Drugs and Medical Devices or the Paul-Ehrlich Institute approves clinical trials in Germany, depending on the product to be investigated. Sofpromed, a full-service CRO, states that Germany is considered one of the best countries in the EU to run clinical trials (within the top three countries in Europe in a number of clinical studies). By June 2021, the US clinical trial portal (clinicaltrials.gov) had registered 21,470 clinical studies with at least one German site. Microbiological testing is crucial in Europe for ensuring quality control, regulatory compliance, and minimizing the risk of microbial contamination.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Microbiology CRO Services Market: Strategic Insights

microbiology-cro-services-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Microbiology CRO Services Market Drivers and Opportunities

Rising Practice of Outsourcing Clinical Studies with Massive Number of Trials Drive Market Growth

According to the National Library of Medicine (NLM), ~52,000 new studies were registered with NLM (ClinicalTrials.gov) in 2020, and the number increased to ~58,000 in 2023. In January 2023, the NLM reported 38,837 active clinical trials in the US and 105,172 active trials worldwide. According to the European Medicine Agency, in the European Union (EU), ~4,000 clinical trials are authorized annually, of which about 60% of studies are associated with the pharmaceutical industry. An upsurge in the number of clinical trials can be attributed to the rising prevalence of chronic diseases worldwide, which creates an immense demand for more effective treatments.

The increasing complexity of clinical trials makes the proper execution and monitoring of operations carried out in research-based organizations crucial. To avoid errors due to improper execution, many research-based organizations outsource clinical trials to clinical research organizations (CROs). Furthermore, CROs assist in successfully implementing clinical trials by offering deep subject matter expertise at high-quality facilities. They have gradually become an important part of the clinical trial industry through their efficient and cost-effective operations that benefit trial sponsors. According to a blog published by Thermo Fisher Scientific, in 2022, CROs executed ~3 out of 4 clinical trials to reassure the clinical programs of drug developers; provide a wealth of expertise; drive time and cost efficiencies; and deliver customized, high-quality data. Thus, the increasing number of clinical trials and the practice of outsourcing trials to CROs to boost cost-effectiveness and reduce errors drive the microbiology CRO market.

Advancements in Microbiology Testing Technology to Offer Opportunities for Microbiology CRO Services Market

The advancements in microbiology testing technology have revolutionized the pharmaceutical and medical device industries. These advancements enable faster, more accurate, and cost-effective detection of microorganisms. A few critical advancements in microbiology testing technology are mentioned below:

• Molecular Diagnostics: Next-generation sequencing (NGS) and polymerase chain reaction (PCR) technologies have enabled rapid detection of microorganisms, allowing for earlier identification of contamination and reduced product recall rates.

• Automated Systems: Automated systems, such as microbiology analyzers and robotic systems, have increased efficiency, reduced labor costs, and improved accuracy in testing.

• Rapid Microbiological Methods: Techniques such as ATP bioluminescence, PCR-based methods, and mass spectrometry have accelerated microbial identification, reducing the time of results from days to hours or even minutes.

• Microbial Identification Systems: Advanced microbial identification systems such as matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry have improved accuracy and speed in identifying microorganisms.

The abovementioned advancements in microbiology testing technology have improved the accuracy, speed, and efficiency of testing. These improvements enable the pharmaceutical and medical device industries to reduce product recall rates, improve product quality, enhance patient safety, increase efficiency and reduce costs, and accelerate product development and launch timelines. This, in turn, has opened up new avenues for pharmaceutical companies to ensure the quality and safety of their products and for medical device manufacturers to ensure the sterility and biocompatibility of their devices.

Microbiology CRO Services Market Report Segmentation Analysis

Key segments that contributed to the derivation of the microbiology CRO services market analysis are service type, application, microorganisms, and end user.

  • Based on service type, the microbiology CRO services market is segmented into assay development, custom viral stock production, microbial testing, and others. The assay development segment held the largest share of the market in 2023.
  • By application, the microbiology CRO services market is segmented into clinical, medical device, and others. The clinical segment held the largest share of the market in 2023.
  • In terms of microorganisms, the microbiology CRO services market is categorized into bacteria, fungi, viruses, and parasites. The bacteria segment dominated the market in 2023.
  • Based on end user, the market is segmented into biotech and pharmaceutical companies, medical device companies, and others. The biotech and pharmaceutical companies segment held the largest share of the market in 2023.

Microbiology CRO Services Market Share Analysis by Geography

The geographic scope of the microbiology CRO services market report is mainly divided into five regions: North America, Asia Pacific, Europe, South & Central America, and the Middle East & Africa. North America dominated the market in 2023. The microbiology CRO market in North America is segmented into the US, Canada, and Mexico. The US is the largest microbiology CRO market and is estimated to dominate the market during the forecast period. The microbiology CRO market growth in the US is driven by the adoption of modern technologies by CROs, the surging number of clinical trials, and increasing investment in research and development by pharmaceutical and biotechnological companies. Also, strategic initiatives by market players play a significant role in supporting the microbiology CRO market growth. For instance, in February 2024, ICON plc acquired Clinical Research Management, Inc. (ClinicalRM). ClinicalRM offers comprehensive research solutions to various US government agencies. The company has extensive expertise in basic and applied research, infectious diseases, vaccine development, testing, and responding to bio-threats. They have collaborated with both government and commercial customers to address the threat of global viral epidemics.

Microbiology CRO Services Market Regional Insights

The regional trends and factors influencing the Microbiology CRO Services Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Microbiology CRO Services Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

microbiology-cro-services-market-global-geography
  • Get the Regional Specific Data for Microbiology CRO Services Market

Microbiology CRO Services Market Report Scope

Report Attribute Details
Market size in 2023 US$ 5.52 Billion
Market Size by 2031 US$ 11.51 Billion
Global CAGR (2023 - 2031) 9.6%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Application
  • Clinical
  • Medical Device
By Service Type
  • Assay Development
  • Custom Viral Stock Production
  • Microbial Testing
By Microorganisms
  • Bacteria
  • Fungi
  • Viruses
  • Parasites
By End User
  • Biotech and Pharmaceutical Companies
  • Medical Device Companies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Microbiologics
  • Melbec Microbiology
  • Emery Pharma
  • TheraIndx Lifesciences Pvt. Ltd.
  • AVERIN BIOTECH
  • Statens Serum Institut
  • ImQuest BioScience
  • PACIFIC BIOLAB
  • Innovotech Inc
  • BluTest Laboratories Ltd

  • Microbiology CRO Services Market Players Density: Understanding Its Impact on Business Dynamics

    The Microbiology CRO Services Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Microbiology CRO Services Market are:

    1. Microbiologics
    2. Melbec Microbiology
    3. Emery Pharma
    4. TheraIndx Lifesciences Pvt. Ltd.
    5. AVERIN BIOTECH
    6. Statens Serum Institut

    Disclaimer: The companies listed above are not ranked in any particular order.


    microbiology-cro-services-market-cagr

    • Get the Microbiology CRO Services Market top key players overview

    Microbiology CRO Services Market News and Recent Developments

    The microbiology CRO services market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the microbiology CRO services market are listed below:

    • Frontage Laboratories, Inc. and its subsidiary, Frontage Canada, Inc., acquired Nucro-Technics Inc. and its affiliate, Nucro-Technics Holdings, Inc., a pharmaceutical contract research organization offering various services. (Source: Frontage Laboratories, Inc; Company Website; August 2023)
    • Pacific BioLabs announced the launch of In Vitro Services. These In Vitro Services offer in vitro, cell-based assays supporting the pharmaceutical, biopharma, and medical device industries. The addition of this group to the PBL testing portfolio increases and is complimentary to well-established testing capabilities in our Microbiology, Analytical/Bioanalytical, and In Vivo departments. (Source: Pacific BioLabs, Company Website, May 2022)

    Microbiology CRO Services Market Report Coverage and Deliverables

    The "Microbiology CRO Services Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

    • Microbiology CRO services market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Microbiology CRO services market trends, as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST and SWOT analysis
    • Microbiology CRO services market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the microbiology CRO services market
    • Detailed company profiles

    Frequently Asked Questions

    What is the expected CAGR of the microbiology CRO services market?

    The market is expected to register a CAGR of 9.6% during 2023–2031.

    What would be the estimated value of the microbiology CRO services market by 2031?

    The microbiology CRO services market is expected to reach US$ 11.51 billion by 2031.

    Which are the leading players operating in the microbiology CRO services market?

    Microbiologics, Melbec Microbiology, Emery Pharma, TheraIndx Lifesciences Pvt. Ltd., AVERIN BIOTECH, Statens Serum Institut, ImQuest BioScience, PACIFIC BIOLAB, Innovotech Inc, and BluTest Laboratories Ltd. are among the key players in the market.

    What are the future trends of the microbiology CRO services market?

    The rise in partnerships and collaborations with service providers is expected to be a prime trend in the market in the coming years.

    What are the driving factors impacting the microbiology CRO services market?

    The rising practice of outsourcing clinical studies with a massive number of trials and surging research and development investments are among the most significant factors fueling the market growth.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies – Microbiology CRO Services Market

    • Microbiologics
    • Melbec Microbiology
    • Emery Pharma
    • TheraIndx Lifesciences Pvt. Ltd.
    • AVERIN BIOTECH
    • Statens Serum Institut
    • ImQuest BioScience
    • PACIFIC BIOLAB
    • Innovotech Inc
    • BluTest Laboratories Ltd.
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo